Guardant Health Secures New Commercial Payor Coverage for Liquid Biopsy Cancer Profiling Test
With new coverage from Anthem Blue Cross and Blue Shield, Aetna, and Humana, the firm's Guardant360/Guardant360 CDx assay is now covered by all major commercial health insurers.
Aetna Updates Noninvasive Prenatal Testing Coverage Policy to Include All Pregnancies
Aetna's move comes at a time when a number of insurers including UnitedHealthcare have begun offering coverage of NIPT for average-risk pregnancies.
CVS Health, Tempus Precision Oncology Program Aims to Aid Oncologists, Improve Patient Outcomes
The CVS-Tempus partnership aims to streamline the cancer care process for patients from the point of prescribing onwards and connect patients with local trials.
A preliminary analysis lends some support to covering NIPS for pregnancies beyond high-risk, and some payors have expanded coverage.
Castle Biosciences Uveal Melanoma Prognostic Test Garners Coverage from Multiple Payors
The company announced positive coverage decisions from Palmetto GBA, 14 BCBS plans, and Aetna.